RA Capital Management’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,525,754
| Closed | -$17.9M | – | 79 |
|
|
2024
Q1 | $17.9M | Hold |
3,525,754
| – | – | 0.23% | 67 |
|
|
2023
Q4 | $9.91M | Hold |
3,525,754
| – | – | 0.15% | 56 |
|
|
2023
Q3 | $10.1M | Hold |
3,525,754
| – | – | 0.2% | 55 |
|
|
2023
Q2 | $17.8M | Buy |
3,525,754
+935,850
| +36% | +$4.73M | 0.34% | 47 |
|
|
2023
Q1 | $4.89M | Hold |
2,589,904
| – | – | 0.11% | 54 |
|
|
2022
Q4 | $4.66M | Hold |
2,589,904
| – | – | 0.09% | 61 |
|
|
2022
Q3 | $4.38M | Hold |
2,589,904
| – | – | 0.09% | 73 |
|
|
2022
Q2 | $6.37M | Hold |
2,589,904
| – | – | 0.17% | 66 |
|
|
2022
Q1 | $7.17M | Hold |
2,589,904
| – | – | 0.16% | 83 |
|
|
2021
Q4 | $13.8M | Hold |
2,589,904
| – | – | 0.24% | 69 |
|
|
2021
Q3 | $21.9M | Hold |
2,589,904
| – | – | 0.3% | 61 |
|
|
2021
Q2 | $31.6M | Hold |
2,589,904
| – | – | 0.51% | 54 |
|
|
2021
Q1 | $62.8M | Hold |
2,589,904
| – | – | 0.95% | 34 |
|
|
2020
Q4 | $83M | Hold |
2,589,904
| – | – | 1.16% | 26 |
|
|
2020
Q3 | $78.3M | Hold |
2,589,904
| – | – | 1.43% | 23 |
|
|
2020
Q2 | $109M | Hold |
2,589,904
| – | – | 2.13% | 16 |
|
|
2020
Q1 | $64.6M | Buy |
+2,589,904
| New | +$64.6M | 2.04% | 19 |
|